Antipodes Partners LTD Certara, Inc. Transaction History
Antipodes Partners LTD
- $2.83 Billion
- Q3 2024
A detailed history of Antipodes Partners LTD transactions in Certara, Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 1,786 shares of CERT stock, worth $24,307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,786Holding current value
$24,307% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CERT
# of Institutions
237Shares Held
105MCall Options Held
26.4KPut Options Held
19.2K-
Black Rock Inc. New York, NY13.4MShares$183 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$169 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT9.02MShares$123 Million0.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.01MShares$109 Million0.02% of portfolio
-
Geneva Capital Management LLC5.46MShares$74.3 Million1.02% of portfolio
About Certara, Inc.
- Ticker CERT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 159,899,008
- Market Cap $2.18B
- Description
- Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...